At the time of writing, Boston Scientific Corp [BSX] stock is trading at $105.02, up 0.05%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BSX shares have gain 1.92% over the last week, with a monthly amount glided 15.04%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Boston Scientific Corp [NYSE: BSX] stock has seen the most recent analyst activity on January 10, 2025, when Deutsche Bank upgraded its rating to a Buy but kept the price target unchanged to $108 for it. Previously, Needham downgraded its rating to Hold on October 18, 2024. On May 30, 2024, Goldman initiated with a Buy rating and assigned a price target of $90 on the stock. Mizuho upgraded its rating to a Buy and increased its price target to $80 on February 01, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $59 as its price target on July 19, 2023. CL King started tracking with a Buy rating for this stock on June 30, 2023, and assigned it a price target of $64.
For the past year, the stock price of Boston Scientific Corp fluctuated between $64.08 and $107.17. Currently, Wall Street analysts expect the stock to reach $100.22 within the next 12 months. Boston Scientific Corp [NYSE: BSX] shares were valued at $105.02 at the most recent close of the market. An investor can expect a potential drop of -4.57% based on the average BSX price forecast.
Analyzing the BSX fundamentals
According to Boston Scientific Corp [NYSE:BSX], the company’s sales were 16.75B for trailing twelve months, which represents an 22.44% jump. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.09 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 104.53 points at the first support level, and at 104.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 105.70, and for the 2nd resistance point, it is at 106.39.
Ratios To Look Out For
It is important to note that Boston Scientific Corp [NYSE:BSX] has a current ratio of 1.48. Further, the Quick Ratio stands at 1.02, while the Cash Ratio is 0.42. Considering the valuation of this stock, the price to sales ratio is 9.24, the price to book ratio is 7.47 and price to earnings (TTM) ratio is 84.17.
Transactions by insiders
Recent insider trading involved Butcher Arthur C, EVP& Grp Pres, MedSurg & APAC, that happened on Feb 03 ’25 when 17313.0 shares were sold. Officer, ARTHUR C BUTCHER completed a deal on Feb 03 ’25 to buy 17313.0 shares. Meanwhile, EVP, Global Operations Sorenson John Bradley sold 4119.0 shares on Jan 02 ’25.
